A detailed history of Advisor Group Holdings, Inc. transactions in Ocugen, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 124,824 shares of OCGN stock, worth $114,838. This represents 0.0% of its overall portfolio holdings.

Number of Shares
124,824
Previous 98,111 27.23%
Holding current value
$114,838
Previous $152,000 19.08%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.98 - $1.95 $26,178 - $52,090
26,713 Added 27.23%
124,824 $123,000
Q2 2024

Aug 13, 2024

BUY
$1.18 - $1.98 $26,048 - $43,708
22,075 Added 29.03%
98,111 $152,000
Q1 2024

May 10, 2024

BUY
$0.5 - $1.83 $21,260 - $77,811
42,520 Added 126.86%
76,036 $124,000
Q4 2023

Feb 12, 2024

BUY
$0.36 - $0.57 $404 - $640
1,124 Added 3.47%
33,516 $19,000
Q3 2023

Nov 13, 2023

BUY
$0.4 - $0.62 $2,216 - $3,435
5,541 Added 20.64%
32,392 $12,000
Q2 2023

Aug 10, 2023

SELL
$0.45 - $0.88 $648 - $1,267
-1,440 Reduced 5.09%
26,851 $14,000
Q1 2023

May 12, 2023

SELL
$0.82 - $1.33 $3,772 - $6,118
-4,600 Reduced 13.99%
28,291 $24,000
Q4 2022

Feb 10, 2023

BUY
$1.11 - $1.87 $12,738 - $21,460
11,476 Added 53.59%
32,891 $42,000
Q3 2022

Nov 14, 2022

BUY
$1.75 - $3.1 $409 - $725
234 Added 1.1%
21,415 $38,000
Q2 2022

Aug 10, 2022

BUY
$1.83 - $3.45 $4,122 - $7,772
2,253 Added 11.9%
21,181 $48,000
Q1 2022

May 04, 2022

SELL
$2.34 - $4.72 $40,823 - $82,345
-17,446 Reduced 47.96%
18,928 $63,000
Q3 2021

Nov 05, 2021

BUY
$6.36 - $8.51 $201,249 - $269,281
31,643 Added 668.84%
36,374 $261,000
Q2 2021

Aug 02, 2021

BUY
$5.52 - $15.68 $8,787 - $24,962
1,592 Added 50.72%
4,731 $38,000
Q1 2021

May 13, 2021

SELL
$1.66 - $15.81 $22,038 - $209,893
-13,276 Reduced 80.88%
3,139 $21,000
Q4 2020

Feb 10, 2021

BUY
$0.28 - $2.6 $4,511 - $41,896
16,114 Added 5353.49%
16,415 $30,000
Q3 2020

Nov 12, 2020

BUY
$0.2 - $0.72 $60 - $216
300 Added 30000.0%
301 $0
Q1 2020

May 18, 2020

BUY
$0.26 - $0.73 $0 - $0
1 New
1 $0

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $199M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.